Thermo Fisher Scientific is a diagnostics & research business based in the US. Thermo Fisher Scientific shares (TMO) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $512.84 – a decrease of 3.79% over the previous week. Thermo Fisher Scientific employs 122,000 staff and has a trailing 12-month revenue of around $42.4 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $512.84 |
|---|---|
| 52-week range | $464.67 - $627.48 |
| 50-day moving average | $588.41 |
| 200-day moving average | $578.77 |
| Wall St. target price | $656.23 |
| PE ratio | 34.0153 |
| Dividend yield | $1.52 (0.29%) |
| Earnings per share (TTM) | $15.67 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $509.12 from 2024-11-19
| 1 week (2024-11-14) | -4.48% |
|---|---|
| 1 month (2024-10-21) | -14.49% |
| 3 months (2024-08-21) | -16.56% |
| 6 months (2024-05-21) | -13.73% |
| 1 year (2023-11-21) | 5.54% |
|---|---|
| 2 years (2022-11-21) | -4.57% |
| 3 years (2021-11-19) | 631.4512 |
| 5 years (2019-11-21) | 68.74% |
Valuing Thermo Fisher Scientific stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Thermo Fisher Scientific's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Thermo Fisher Scientific's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 34x. In other words, Thermo Fisher Scientific shares trade at around 34x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Thermo Fisher Scientific's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0564. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Thermo Fisher Scientific's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Thermo Fisher Scientific's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $10.6 billion.
The EBITDA is a measure of a Thermo Fisher Scientific's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $42.4 billion |
|---|---|
| Operating margin TTM | 18.06% |
| Gross profit TTM | $19 billion |
| Return on assets TTM | 4.67% |
| Return on equity TTM | 12.94% |
| Profit margin | 14.48% |
| Book value | $128.08 |
| Market Capitalization | $203.9 billion |
TTM: trailing 12 months
Dividend payout ratio: 7.09% of net profits
Recently Thermo Fisher Scientific has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Thermo Fisher Scientific shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Thermo Fisher Scientific's case, that would currently equate to about $1.52 per share.
While Thermo Fisher Scientific's payout ratio might seem low, this can signify that Thermo Fisher Scientific is investing more in its future growth.
Thermo Fisher Scientific's most recent dividend payout was on 14 January 2025. The latest dividend was paid out to all shareholders who bought their shares by 12 December 2024 (the "ex-dividend date").
Thermo Fisher Scientific's shares were split on a 3:2 basis on 5 June 1996 . So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Thermo Fisher Scientific shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Thermo Fisher Scientific shares which in turn could have impacted Thermo Fisher Scientific's share price.
Over the last 12 months, Thermo Fisher Scientific's shares have ranged in value from as little as $464.667 up to $627.4813. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Thermo Fisher Scientific's is 0.792. This would suggest that Thermo Fisher Scientific's shares are less volatile than average (for this exchange).
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.